Interview: Mike Kennedy: Chief Strategy Officer: Green Check Verified
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Ohio Sets New Package and Potency Limits for Cannabis Products
COLUMBUS – The Ohio Department of Commerce Division of Cannabis Control adopted the rule, which applies to products intended for direct sale to recreational consumers and medical patients. It generally bars products from exceeding 90% ...
Curaleaf Secures Australian Approval for Medical Cannabis Inhaler, Lists in New Zealand
LONDON – Curaleaf International, part of Curaleaf Holdings, Inc., in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Device (QMID) has been registered by Australia's Therapeutic Goods Administration (TGA) as a Class ...
BetterLife Closes $100M Offering for Neurological Drug Pipeline
VANCOUVER – BetterLife Pharma Inc. closed a US$100 million public offering, providing capital to take its lead candidate through Phase I and Phase II clinical trials for cluster headache and migraine. Deep Track Capital led ...
